Cargando…
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
PURPOSE: The molecular characterization of circulating tumor cells (CTCs) is critical to identify the key drivers of cancer metastasis and devising therapeutic approaches, particularly for inflammatory breast cancer (IBC) which is usually diagnosed at advance stages and progresses rapidly. METHODS:...
Autores principales: | Bingham, Catherine, Fernandez, Sandra V., Fittipaldi, Patricia, Dempsey, Paul W., Ruth, Karen J., Cristofanilli, Massimo, Katherine Alpaugh, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410214/ https://www.ncbi.nlm.nih.gov/pubmed/28271309 http://dx.doi.org/10.1007/s10549-017-4176-x |
Ejemplares similares
-
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014) -
Inflammatory breast cancer (IBC): clues for targeted therapies
por: Fernandez, Sandra V., et al.
Publicado: (2013) -
No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression
por: Förnvik, Daniel, et al.
Publicado: (2013) -
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer
por: Beck, Tim N., et al.
Publicado: (2019) -
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
por: Liu, Xiaoran, et al.
Publicado: (2021)